This website is part of the ECDC (European Centre for Disease Prevention and Control) network

Surveillance and disease data

Main developments

This page was updated on 11 October 2016

 Get the latest surveillance data on measles from EU and EEA countries through the Surveillance Atlas of Infectious Diseases. 

  • Between 1 November 2015 and 31 October 2016, 30 EU/EEA Member States reported 3 037 cases of measles. Twenty-eight Member States reported consistently throughout the 12-month period. Croatia and Cyprus did not report data for October 2016.
  • The highest numbers of cases were reported by Romania (1 011), Italy (728) and the United Kingdom (569), accounting respectively for 33%, 24% and 19% of the EU/EEA cases in the 12-month period.
  • Measles is targeted for elimination in Europe. The measles notification rate was below the elimination target (one case per million population) in 17 of the 30 reporting countries. Nine of these Member States reported zero cases. The highest notification rates were observed in Romania (50.9), Italy (12.0 and Ireland (11.0).
  • The diagnosis of measles was confirmed by positive laboratory results (serology, virus detection or isolation) in 72% of all cases.
  • Of all cases with known age (n=3 031), 1 213 (40%) were children less than 5 years of age, while 892 (29%) were aged 20 years or over. The highest incidence was reported in children below one year of age (55.4 per million) and children between 1 and 4 years of age (43.6 per million).
  • Of the cases with known age, 81% were unvaccinated, 8% were vaccinated with one dose, 3% were vaccinated with two or more doses, 1% were vaccinated with an unknown number of doses and 7% had an unknown vaccination status.
  • The proportion of cases with unknown vaccination status was highest in adults aged 30 years and over, reaching 15% in this age group. The proportion of unvaccinated cases was highest among children below one year of age (98%). This is expected as these children are too young to have received the first dose of measles vaccine. Infants are particularly vulnerable to complications of measles and are best protected by herd immunity which is achieved when population coverage for the second dose of a measles-containing vaccine is at least 95%.
  • In the target group for routine childhood MMR vaccination (1-4 year-olds), 83% of the cases were unvaccinated, 11% were vaccinated with one dose, 1% with two doses or more, 1% with an unknown number of doses and 4% had an unknown vaccination status.
  • Seven deaths due to measles were reported during the 12-month period, six in Romania and one in the United Kingdom. Four were in children under 12 months of age who are not eligible for vaccination according to their national schedule. Three occurred in persons with underlying medical conditions.
  • Recent reports of measles outbreaks in the EU (United Kingdom and Romania) and outside the EU (Liberia and Sudan) have been detected by epidemic intelligence. See the CDTR.
 

 This section

 

Monitoring reports
These reports are based on enhanced surveillance from ECDC, national websites, the Early Warning and Response System (EWRS), validated media reports, and communication for national authorities.

Measles maps
Maps of measles cases on a monthly basis,reported by EU/EEA countries to ECDC via The European Surveillance System (TESSy).

Archive: EUVAC.net reports
Surveillance reports of selected vaccine-preventable diseases published by EUVAC.Net from 1999 to 2011.

 

 Measles and rubella monitoring reports

 
© European Centre for Disease Prevention and Control (ECDC) 2005 - 2017